Renal Cancer - Results from #5680

Anti-Tumor Effect via Passive Anti-angiogenesis of PEGylated Liposomes Encapsulating Doxorubicin in Drug Resistant Tumors May 30, 2016

Racial disparities in renal cell carcinoma: a single-payer healthcare experience May 29, 2016

The Value of Contrast-Enhanced Ultrasonography and Contrast-Enhanced CT in the Diagnosis of Malignant Renal Cystic Lesions: A Meta-Analysis May 27, 2016

Survival in Patients with Primary Metastatic Renal Cell Carcinoma Treated with Sunitinib with or Without Previous Cytoreductive Nephrectomy: Results From a Population-Based Registry May 26, 2016

Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours May 26, 2016

Risk Factors for De Novo Malignancies in Women After Kidney Transplantation: A Multicenter Transversal Study May 25, 2016

A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies May 25, 2016

Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy May 25, 2016

Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials May 24, 2016

Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity May 24, 2016

Outcomes of minimal invasive vs open radical nephrectomy for the treatment of locally advanced renal cell carcinoma May 24, 2016

Rapalogs efficacy relies on the modulation of antitumor T cell immunity May 23, 2016

Cancer therapy directed by comprehensive genomic profiling: a single center study May 23, 2016

Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin May 19, 2016

Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer May 19, 2016

Immunotherapy for genitourinary cancer: state of the art and new perspectives May 19, 2016

Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma-Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study May 19, 2016

ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells May 18, 2016

The role of micronutrients in the risk of urinary tract cancer May 18, 2016

Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma May 18, 2016

Page 285 of 456